Thermo Fisher Scientific Inc (TMO) - Total Liabilities
Based on the latest financial reports, Thermo Fisher Scientific Inc (TMO) has total liabilities worth $52.00 Billion USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore TMO net asset momentum to track the company's year-over-year net asset growth rate.
Thermo Fisher Scientific Inc - Total Liabilities Trend (1985–2024)
This chart illustrates how Thermo Fisher Scientific Inc's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Thermo Fisher Scientific Inc to measure how efficiently the company converts operating cash flow to free cash.
Thermo Fisher Scientific Inc Competitors by Total Liabilities
The table below lists competitors of Thermo Fisher Scientific Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Nestlé S.A
F:NESM
|
Germany | €101.08 Billion |
|
Arm Holdings plc American Depositary Shares
NASDAQ:ARM
|
USA | $2.42 Billion |
|
BHP Group Ltd
AU:BHP
|
Australia | AU$60.59 Billion |
|
Novartis AG
SW:NOVN
|
Switzerland | CHF79.84 Billion |
|
American Express Company
NYSE:AXP
|
USA | $274.90 Billion |
|
Citigroup Inc.
NYSE:C
|
USA | $2.57 Trillion |
|
Nestle S.A.
SW:NESN
|
Switzerland | CHF94.09 Billion |
|
Bank of China Limited
SHG:601988
|
China | CN¥36.35 Trillion |
Liability Composition Analysis (1985–2024)
This chart breaks down Thermo Fisher Scientific Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see TMO stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.50 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.02 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.50 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Thermo Fisher Scientific Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Thermo Fisher Scientific Inc (1985–2024)
The table below shows the annual total liabilities of Thermo Fisher Scientific Inc from 1985 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $47.65 Billion | -8.16% |
| 2023-12-31 | $51.88 Billion | -2.12% |
| 2022-12-31 | $53.01 Billion | -2.11% |
| 2021-12-31 | $54.15 Billion | +56.79% |
| 2020-12-31 | $34.53 Billion | +20.31% |
| 2019-12-31 | $28.71 Billion | +0.21% |
| 2018-12-31 | $28.65 Billion | -8.35% |
| 2017-12-31 | $31.26 Billion | +28.27% |
| 2016-12-31 | $24.37 Billion | +25.07% |
| 2015-12-31 | $19.48 Billion | -12.64% |
| 2014-12-31 | $22.30 Billion | +48.62% |
| 2013-12-31 | $15.01 Billion | +25.27% |
| 2012-12-31 | $11.98 Billion | +1.56% |
| 2011-12-31 | $11.80 Billion | +95.75% |
| 2010-12-31 | $6.03 Billion | -2.34% |
| 2009-12-31 | $6.17 Billion | +0.11% |
| 2008-12-31 | $6.16 Billion | -8.27% |
| 2007-12-31 | $6.72 Billion | -8.59% |
| 2006-12-31 | $7.35 Billion | +404.05% |
| 2005-12-31 | $1.46 Billion | +60.04% |
| 2004-12-31 | $911.17 Million | -9.44% |
| 2003-12-31 | $1.01 Billion | -37.65% |
| 2002-12-31 | $1.61 Billion | -15.51% |
| 2001-12-31 | $1.91 Billion | -17.11% |
| 2000-12-31 | $2.30 Billion | -17.57% |
| 1999-12-31 | $2.80 Billion | -16.30% |
| 1998-12-31 | $3.34 Billion | +11.88% |
| 1997-12-31 | $2.99 Billion | +13.67% |
| 1996-12-31 | $2.63 Billion | +34.27% |
| 1995-12-31 | $1.96 Billion | +14.92% |
| 1994-12-31 | $1.70 Billion | +28.64% |
| 1993-12-31 | $1.32 Billion | +20.76% |
| 1992-12-31 | $1.10 Billion | +85.54% |
| 1991-12-31 | $590.50 Million | +18.48% |
| 1990-12-31 | $498.40 Million | +37.91% |
| 1989-12-31 | $361.40 Million | +17.11% |
| 1988-12-31 | $308.60 Million | +16.76% |
| 1987-12-31 | $264.30 Million | +62.05% |
| 1986-12-31 | $163.10 Million | +35.80% |
| 1985-12-31 | $120.10 Million | -- |
About Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines,… Read more